1 results match your criteria: "Hospital de la Santa Crue i Sant Pau-U.A.B.[Affiliation]"
Pharmacokinetics of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency.
Clin Pharmacol Ther
November 1999
Pharmacological Research Area, Institut de Recerca, Hospital de la Santa Crue i Sant Pau-U.A.B., Barcelona, Spain.
Objective: To characterize the pharmacokinetic profile of the somatostatin analog lanreotide in patients with severe chronic renal insufficiency.
Methods: Lanreotide was administered by intravenous bolus (7 microg/kg) to 12 patients with severe chronic renal insufficiency and to 12 healthy subjects. Lanreotide serum levels were determined by a radioimmunoassay procedure from time 0 until 24 hours after the administration.